OVID compared with RZLT: revenue, margins and what each company keeps, and the suppliers and customers both name

OVIDOvid Therapeutics Inc.

Mkt capRevenueRevenue

RZLTRezolute, Inc.

Mkt capRevenueRevenue

Compare

OVIDOvid Therapeutics Inc.

RZLTRezolute, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

OVID

No earnings history for OVID.

RZLT

0 of 4at or beyond implied

Reportimpliedrealized× implied

Sep 25 '26±44.2%▼−1.02%×0.02

Q3 FY26±23.5%▲+0.91%×0.04

Q2 FY26±28.3%▲+5.79%×0.20

Nov 7 '25±31.0%▲+12.08%×0.39

= impliedOVID realized, solidRZLT realized, hatchedOne scale, both sides: full bar = 45%× = |realized| ÷ impliedSource: market data

OVIDOvid Therapeutics Inc.

2.40▼−5.32%

Mkt cap$496.1MRevenue$733,000Q2 FY26Revenue$7MFY25

RZLTRezolute, Inc.

3.85▼−2.66%

Regular sessionNov 2 '26

Mkt cap$382.1MRevenue—Revenue—

Compare

Regular sessionNov 2 '26

OVIDOvid Therapeutics Inc.

RZLTRezolute, Inc.

2.40▼−5.32%

Price

3.85▼−2.66%

$496.1M

Mkt cap

$382.1M

Q2 FY26$733,000

Revenue

—

FY25$7M

Revenue

—

OVID2.40▼−5.32%vsRZLT3.85▼−2.66%Regular sessionNov 2 '26